Follow The Filings

RXO

Earnings company data as of 10:00 AM ET 10/23

Scheduled

1 period, newest first, nothing reported yet. Each row shows EPS above revenue.

Period Date Metric Estimate Actual Result
FY2026 Q3 5 Nov EPS 0.07 — —
Rev — — —

Insider trades

Open-market buys and sales by RXO's executives, directors and 10% owners in the last 12 months, from their Form 4s

All RXO insider trades
  • $7M bought by 5 insiders
  • $386K sold by 1 insider outside a trading plan
  • None no planned (10b5-1) sales
  1. MFN Partners, LP 10% owner, +5 joint filers
    Buy
    $6.4M 532,276 shares at $12.00 +1.9% to stake
    Traded Feb 12 Filed Feb 17
  2. Troy A. Cooper Director
    Buy
    $88K 8,317 shares at $10.61 +3.1% to stake
    Traded Nov 20, 2025 Filed Nov 24, 2025
  3. Adrian Kingshott Director
    Buy
    $101K 9,350 shares at $10.75 +11% to stake
    Traded Nov 17, 2025 Filed Nov 19, 2025
  4. Jason S. Kerr Chief Accounting Officer
    Sale
    $386K 33,343 shares at $11.57 43% of stake
    Traded Nov 10, 2025 Filed Nov 12, 2025
  5. Thomas A Szlosek Director
    Buy
    $251K 20,308 shares at $12.37 +125% to stake
    Traded Nov 7, 2025 Filed Nov 12, 2025
  6. Andrew M. Wilkerson CEO
    Buy
    $149K 11,625 shares at $12.85
    Traded Nov 10, 2025 Filed Nov 10, 2025

Also filed in the last 12 months, not counted as buying or selling: 20 option exercises, 16 share withholdings for taxes, and 4 gifts.

SEC filings

Recent issuer filings from EDGAR, 22 shown.

Filed Form Detail Links
SCHEDULE 13D —
8-K 1.01,8.01,9.01
8-K 7.01,9.01
SCHEDULE 13G/A —
8-K 2.02,7.01,9.01
10-Q
SCHEDULE 13G/A —
8-K 5.07
8-K 2.02,7.01,9.01
10-Q
SCHEDULE 13G —
SCHEDULE 13G —
DEF 14A
DEFA14A
SCHEDULE 13G/A —
8-K 1.01,2.03,8.01,9.01
SCHEDULE 13G/A —
SCHEDULE 13G —
8-K 7.01,9.01
SCHEDULE 13G/A —
8-K 7.01,9.01
10-K

Estimates are consensus figures; SEC filings remain the official record. Not investment advice.